Detail page

Knowledge Web

Person

Roland Penzel

Arzt

Name	Roland Penzel
Place	Deutschland
Gender	männlich
Academic degree	Dr. rer. nat.
Profession	Arzt (characteristic profession)
Variant	R. Penzel
Further information	Wissenschaftlicher Mitarbeiter im Pathologischen Institut des Universitätsklinikums Heidelberg
Record type	Person
GND-Identifier	102044021X
Record ID	102044021X
Involved in show all Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity Struktur und Inhalt der EU-IVDR : Bestandsaufnahme und Implikationen für die Pathologie Von der Paneldiagnostik zu umfassenden genomischen Analysen : Informationsüberfluss oder Zugewinn? Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trial Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma Precision oncology based on omics data: the NCT Heidelberg experience Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient: a case report NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases KRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE) TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities KRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE) Molekulare Diagnostik in der Pathologie Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Roland Penzel

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

Struktur und Inhalt der EU-IVDR : Bestandsaufnahme und Implikationen für die Pathologie

Von der Paneldiagnostik zu umfassenden genomischen Analysen : Informationsüberfluss oder Zugewinn?

Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance

EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trial

Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma

Precision oncology based on omics data: the NCT Heidelberg experience

Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient: a case report

NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial

Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases

KRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE)

TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities

KRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE)

Molekulare Diagnostik in der Pathologie

Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors